ONC001

N/A

Report date: 2025/12/05 14:49:10

Base Information

Drug NameONC001
Drug Alias NameONC001ONC-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionHigh affinity immunoglobulin gamma Fc receptor I antagonists
TargetsHigh affinity immunoglobulin gamma Fc receptor I
Therapy Area/IndicationsLeukemia, Myelomonocytic, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOncoPrecision Corporation
China Registration ClassN/A

Develop Information

Active CompaniesOncoPrecision Corporation
Inactive CompaniesN/A
Active IndicationsLeukemia, Myelomonocytic, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A